Merck & Co. (MRK)
(Delayed Data from NYSE)
$131.09 USD
-0.01 (-0.01%)
Updated May 23, 2024 04:00 PM ET
Pre-Market: $131.16 +0.07 (0.05%) 9:00 AM ET
3-Hold of 5 3
C Value A Growth C Momentum B VGM
Brokerage Reports
Merck & Co., Inc. [MRK]
Reports for Purchase
Showing records 241 - 260 ( 394 total )
Company: Merck & Co., Inc.
Industry: Large Cap Pharmaceuticals
Company: Merck & Co., Inc.
Industry: Large Cap Pharmaceuticals
Company: Merck & Co., Inc.
Industry: Large Cap Pharmaceuticals
Company: Merck & Co., Inc.
Industry: Large Cap Pharmaceuticals
Company: Merck & Co., Inc.
Industry: Large Cap Pharmaceuticals
Company: Merck & Co., Inc.
Industry: Large Cap Pharmaceuticals
Company: Merck & Co., Inc.
Industry: Large Cap Pharmaceuticals
Company: Merck & Co., Inc.
Industry: Large Cap Pharmaceuticals
Company: Merck & Co., Inc.
Industry: Large Cap Pharmaceuticals
Company: Merck & Co., Inc.
Industry: Large Cap Pharmaceuticals
Company: Merck & Co., Inc.
Industry: Large Cap Pharmaceuticals
Company: Merck & Co., Inc.
Industry: Large Cap Pharmaceuticals
Company: Merck & Co., Inc.
Industry: Large Cap Pharmaceuticals
Immuno-Oncology Key Opinion Leader Conference Call Recap
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R